Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Go back to Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
(NASDAQ: KNSA) Delayed: 55.11 --0 (-0%)
Previous Close $55.11    52 Week High
Open $55.11    52 Week Low
Day High $55.11    P/E N/A 
Day Low $55.11    EPS
Volume 9,423